Accumulation of miR-155 and BIC RNA in human B cell lymphomas
- PMID: 15738415
- PMCID: PMC552785
- DOI: 10.1073/pnas.0500613102
Accumulation of miR-155 and BIC RNA in human B cell lymphomas
Abstract
We show that the microRNA miR-155 can be processed from sequences present in BIC RNA, a spliced and polyadenylated but non-protein-coding RNA that accumulates in lymphoma cells. The precursor of miR-155 is likely a transient spliced or unspliced nuclear BIC transcript rather than accumulated BIC RNA, which is primarily cytoplasmic. By using a sensitive and quantitative assay, we find that clinical isolates of several types of B cell lymphomas, including diffuse large B cell lymphoma (DLBCL), have 10- to 30-fold higher copy numbers of miR-155 than do normal circulating B cells. Similarly, the quantities of BIC RNA are elevated in lymphoma cells, but ratios of the amounts of the two RNAs are not constant, suggesting that the level of miR-155 is controlled by transcription and processing. Significantly higher levels of miR-155 are present in DLBCLs with an activated B cell phenotype than with the germinal center phenotype. Because patients with activated B cell-type DLBCL have a poorer clinical prognosis, quantification of this microRNA may be diagnostically useful.
Figures
![Fig. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1062888/bin/zpq0100575900001.gif)
![Fig. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1062888/bin/zpq0100575900002.gif)
![Fig. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1062888/bin/zpq0100575900003.gif)
![Fig. 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1062888/bin/zpq0100575900004.gif)
![Fig. 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1062888/bin/zpq0100575900005.gif)
Similar articles
-
BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas.J Pathol. 2005 Oct;207(2):243-9. doi: 10.1002/path.1825. J Pathol. 2005. PMID: 16041695
-
Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis.Haematologica. 2016 Nov;101(11):1380-1389. doi: 10.3324/haematol.2016.143891. Epub 2016 Jul 6. Haematologica. 2016. PMID: 27390358 Free PMC article.
-
Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma.Cancer Genet Cytogenet. 2008 Feb;181(1):8-15. doi: 10.1016/j.cancergencyto.2007.10.008. Cancer Genet Cytogenet. 2008. PMID: 18262046 Free PMC article.
-
Regulation of the MIR155 host gene in physiological and pathological processes.Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Gene. 2013. PMID: 23246696 Review.
-
[Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].Gan To Kagaku Ryoho. 2007 Jul;34(7):975-82. Gan To Kagaku Ryoho. 2007. PMID: 17637530 Review. Japanese.
Cited by
-
MiRNA expression as outcome predictor in pediatric AML: systematic evaluation of a new model.NPJ Genom Med. 2024 Aug 6;9(1):40. doi: 10.1038/s41525-024-00424-w. NPJ Genom Med. 2024. PMID: 39107334 Free PMC article.
-
HSV-1 and Cellular miRNAs in CSF-Derived Exosomes as Diagnostically Relevant Biomarkers for Neuroinflammation.Cells. 2024 Jul 17;13(14):1208. doi: 10.3390/cells13141208. Cells. 2024. PMID: 39056790 Free PMC article.
-
Carcinogenic mechanisms of virus-associated lymphoma.Front Immunol. 2024 Feb 28;15:1361009. doi: 10.3389/fimmu.2024.1361009. eCollection 2024. Front Immunol. 2024. PMID: 38482011 Free PMC article. Review.
-
MicroRNAs: Potential prognostic and theranostic biomarkers in chronic lymphocytic leukemia.EJHaem. 2024 Feb 11;5(1):191-205. doi: 10.1002/jha2.849. eCollection 2024 Feb. EJHaem. 2024. PMID: 38406506 Free PMC article. Review.
-
Macrophage polarization in spinal cord injury repair and the possible role of microRNAs: A review.Heliyon. 2023 Nov 27;9(12):e22914. doi: 10.1016/j.heliyon.2023.e22914. eCollection 2023 Dec. Heliyon. 2023. PMID: 38125535 Free PMC article. Review.
References
-
- Haasch, D., Chen, Y. W., Reilly, R. M., Chiou, X. G., Koterski, S., Smith, M. L., Kroeger, P., McWeeny, K., Halbert, D. N., Mollison, K. W., et al. (2002) Cell. Immunol. 217, 78-86. - PubMed
-
- Metzler, M., Wilda, M., Busch, K., Viehmann, S. & Borkhardt, A. (2004) Genes Chromosomes Cancer 39, 167-169. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical